Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.



A tumor-sensitive biological metal–organic complex for drug delivery and cancer therapy

Author affiliations

Abstract

Metal–organic complexes (MOCs) or metal–organic frameworks (MOFs) have attracted increasing interest for constructing nanoscale drug delivery systems for cancer therapy. However, conventional MOC/MOF materials usually contain toxic metals or low-biocompatible organic ligands. Also, current approaches for creating tumor-sensitive nanocarriers are always based on the instability of coordination bonds under acidic conditions, or through post-synthetic modification with sensitive molecules. As a matter of fact, it is more facile to fabricate tumor-sensitive MOCs/MOFs based on the stimuli-responsiveness of organic ligands. In this study, a novel tumor-sensitive biological MOC (bioMOC-Zn(Cys)) was created through the assembly of endogenous Zn2+ ions and the small biological molecule (L-cystine, Cys). The disulfide bond in L-cystine is cleavable by the overexpressed GSH in tumor cells, thus achieving rapid release of drugs from nanocarriers. By encapsulating doxorubicin (DOX) in bioMOC-Zn(Cys), DOX@bioMOC-Zn(Cys) displayed higher cellular uptake and cytotoxicity in cancer cells than free DOX. In vivo investigations indicated that DOX@bioMOC-Zn(Cys) largely inhibited tumor growth and reduced side effects. Remarkably, since both metal ions and organic ligands were obtained from biological sources, bioMOC-Zn(Cys) exhibited superior biocompatibility. This study presents a new method for fabricating MOC-based nanodrugs with high tumor-sensitivity and low toxicity.

Graphical abstract: A tumor-sensitive biological metal–organic complex for drug delivery and cancer therapy

Back to tab navigation

Supplementary files

Article information


Submitted
05 Mar 2020
Accepted
22 Jun 2020
First published
23 Jun 2020

J. Mater. Chem. B, 2020, Advance Article
Article type
Paper

A tumor-sensitive biological metal–organic complex for drug delivery and cancer therapy

Z. Jiang, T. Wang, S. Yuan, M. Wang, W. Qi, R. Su and Z. He, J. Mater. Chem. B, 2020, Advance Article , DOI: 10.1039/D0TB00599A

Social activity

Search articles by author

Spotlight

Advertisements